Tomoko Kanno

1.6k citations
38 papers · 1.4k indexed · h-index 21

Tomoko Kanno

38 papers receiving 1.3k citations

Peers

Tomoko Kanno
Comparison fields: 5 of 110
  • Aging 38
  • Clinical Biochemistry 84
  • Biochemistry 85
  • Biochemistry 70
  • Physiology 281
Replace Kent A. Robinson with:
Kent A. Robinson United States
Hsiu‐Chuan Yen Taiwan
J Wilhelm Czechia
Nadeene Parker United Kingdom
Ellen L. Robb Canada
Cécile Batandier France
Samantha Giordano United States
Tatyana V. Votyakova United States
Alessandra Mocali Italy
Marı́a Cecilia Carreras Argentina
Tomoko Kanno relative to Kent A. Robinson United States Kent A. Robinson's profile →
Citations per field
00.5×1.6×
Kent A. Robinson · 1×
Citations per year

Countries citing papers authored by Tomoko Kanno

Since Specialization
Citations

This map shows the geographic impact of Tomoko Kanno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Kanno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Kanno more than expected).

Fields of papers citing papers by Tomoko Kanno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Kanno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Kanno. The network helps show where Tomoko Kanno may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tomoko Kanno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tomoko Kanno Line = papers co-authored together Tomoko Kanno links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 201240
3 200410
4
Cepharanthine, an anti-inflammatory drug, suppresses mitochondrial membrane permeability transition.
200313
5 2003109
6 200320
7 20034
8 200139
9 2001118
10 200056
11 199918
12 199950
13 19993
14 1998107
15 199730
16 1995131
17 199541
18 19956
19 199530
20 199410

About Tomoko Kanno

Tomoko Kanno is a scholar working on Biochemistry, Toxicology and Aging, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (10 papers), Cell death mechanisms and regulation (7 papers), Coenzyme Q10 studies and effects (4 papers), Free Radicals and Antioxidants (4 papers), Environmental Toxicology and Ecotoxicology (4 papers), ATP Synthase and ATPases Research (4 papers), Antioxidant Activity and Oxidative Stress (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Aging (38 citations), Clinical Biochemistry (84 citations) and Biochemistry (85 citations). Tomoko Kanno has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Kozo Utsumi, Masayasu Inoue, Toshihiko Utsumi, Jitsuo Akiyama, Tamotsu Yoshioka, Yoshiki Takehara, Kayo Arita, Shikibu Muranaka, Hirofumi Fujita and Yoko Inai. Their work appears in journals such as Biochemical Journal, Free Radical Biology and Medicine and Archives of Biochemistry and Biophysics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026